$ Value
$62K
Shares
1,200
Price
$52
Filed
Oct 10
Insider
Name
NEWHALL CHARLES W III
Title
—
CIK
0001005544
Roles
Transaction Details
Transaction Date
2025-10-09
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
104,644
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted March 3, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.12 to $51.08. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.39 to $51.76. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Filing Info
NEWHALL CHARLES W III's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-21 | SUPN | M | $195K |
| 2025-11-21 | SUPN | M | $0 |
| 2025-10-09 | SUPN | ▼ | $1.2M |
| 2025-10-09 | SUPN | ▼ | $62K |
| 2025-08-27 | SUPN | ▼ | $161K |
| 2025-08-25 | SUPN | ▼ | $45K |
| 2025-08-22 | SUPN | ▼ | $64K |
Other Insiders at SUPN (90d)
No other insider activity at this issuer in the last 90 days.